Try our Advanced Search for more refined results
Life Sciences - September, 2017
296 articles
- Generic Drug Lobby Can't Derail Md. Price-Gouging Law
- Dems Urge ACA Reset After HHS Boss Price Resigns
- Fed. Circ. Clears Boston Scientific In $200M Stent IP Case
- Alere Follow-On Challenge Denied Under New PTAB Guidance
- Boston Doctor Charged With Medicaid 'Double Dipping'
- VHA May Have Overpaid For Prosthetics, Watchdog Says
- Boston Boomtown: Life Sciences Driving Firm Expansions
- Celgene Hit With Expansive Antitrust Suit Over Thalomid
- PE-Backed PQ Pulls In $508M In Downsized IPO
- HHS Chief Price Resigns Amid Jet Travel Scandal
- Bayer Further Trims Covestro Stake With €1B Sale
- Ex-Katten Atty Seeks Jurors Without 'Pharma Bro' Baggage
- Health Hires: Jones Day, K&L Gates, Pierce Atwood
- FTC Loses Challenge To Popular Memory Booster Prevagen
- Judge Axes Suit Claiming GSK Landed Pair In Chinese Jail
- 4th Amendment And Shared Servers: Lessons From Shkreli
- Consider Value Vs. Budget Impact In Mass. Drug Prices
- Abbott, Alere Settle Watchdogs' Issues With $5.3B Deal
- TV Streamer Roku Leads 4 IPOs Raising $522M Combined
- Hospira Challenges Amgen's $70M Biosimilar Verdict
- Patients Who Sued Menendez Doc Get Only $1M From Insurer
- Valeant Used 'Clandestine Network' To Cook Books, Says Suit
- Attys Who Don't Correct Patent Examiners 'Sleazy': Judge
- Missing Doctor Doesn't Doom Abbott Depakote Case, For Now
- J&J Loses Bid For Rehearing Of FCA Ruling By 1st Circ.
- Becton Dickinson Offers EU Fixes For Planned $24B Bard Buy
- New Sedona Principles Stress Information Governance
- AbbVie, Amgen End Patent Fight Over Humira Biosimilar
- Alere Settles SEC Fraud Probe With $13M Payout
- Who Will Rescue The US Patent System?
- Owner Of Meningitis-Linked Pharmacy Must Forfeit $7.5M
- FDA Brass, BigLaw Attys Dish On New Promo Policies
- Czech Republic Wins Dismissal of $374M Arbitral Award
- Things To Consider Before A Patent Deal With A Tribe
- 9th Circ. Won't Revisit Key FCA Ruling Against Gilead
- Sens. Seek Investigation Of Allergan's Patent Deal With Tribe
- Woman Fights J&J's New Trial Bid After $417M Talc Verdict
- Cynosure Hit With Class Action Over 'Useless' Body System
- Medical Device Co. Blasts Geico's 'Shotgun' Kickback Suit
- Becton Planted Article To Quash Competition, Suit Says
- GSK Asks 7th Circ. For New Trial In Atty Suicide Suit
- FTC Strikes Deal Over Integra's $1B Offer For J&J Unit
- AmerisourceBergen To Pay $260M After Mislabeling Drugs
- Endo Hit With Pa. Class Action Over Opioid Marketing
- Meningitis Pharmacy Treated 'Donald Duck' And Other Fakes
- For More Value And Diversity In Outside Counsel, Go Small
- Judge Orders Beauty Co. To Stop Selling Unapproved Drugs
- The Unclear Scope Of 'All Patent Rights' In Patent Exhaustion
- St. Jude Scores Arbitration On Ex-Worker's Wage Claims
- Ex-Hunton Atty Avoids Jail For Wine-Fueled Insider Trading
- FDA Warning Wire: Inspector Blocked At Chinese Drug Co.
- Sanofi Urges Judge To Dump Antitrust Suit Over Lantus
- Sofia Vergara's Ex-Fiancé Loses Bid To End Pre-Embryo Suit
- California Proton Sale, Contractor Settlement Approved
- Deals Rumor Mill: IQiyi, Alvogen, JC Flowers
- OxyContin Maker Can't Flee City's Suit Over Opioid Crisis
- Minimize Marijuana Risks With Special Lease Clauses
- Pharmacy Seeks Plan Reinstatement In $1.5B Antitrust Suit
- Forest Labs Must Produce Mylan Docs In Antitrust Suit
- Top White Collar Crime Cases To Watch In Massachusetts
- US Asks High Court To Hold Off On 2 AIA Cases
- PTAB Invalidates Jevtana Patent Claims In Mylan Challenge
- Drugmakers Beat Health Plan's Generic Price Inflation Suit
- 16 States Won't Intervene In FCA Suit Against Compounder
- Pension Fund's Actos Suit Against Takeda Moved To Illinois
- Data Center Co. Switch Leads 2 IPOs Totaling $569M
- Amgen Hits Mylan With Patent Suit Over Neulasta Biosimilar
- FDA Cracks Down On Online Sales Of Prescription Drugs
- Ex-ArthroCare CEO Wants $750M Fraud Conviction Nixed
- Judge Rips Insider Trading Suspect's 'Arrogance'
- Manufacturers Must Focus On Securing The Internet Of Things
- How Plaintiffs And Defense Counsel Misperceive Each Other
- Mass. Marijuana Laws Could Have Far-Reaching Impact
- Amgen Gets $70M In Biosimilar Patent Suit Against Hospira
- Ex-Hunton Atty Seeks No Jail Time For Tipping Off Friend
- Drug Cos. Behind On Safety Studies, Researchers Say
- Merck's Idenix Denied Enhanced Damages On $2.5B Verdict
- 5 Firms To Guide IPOs Totaling $1.25B As Deals Gain Steam
- Taxation With Representation: Cravath, Hogan, Skadden
- CVS Customers Kiss Drug Packaging Claims Goodbye
- Restasis Patent Challenges Must Be Tossed, Tribe Tells PTAB
- Aegerion To Pay $40M To End Host Of Juxtapid Claims
- Pharma Insider-Trading Suspect Arrested Again
- Meningitis Pharmacist Shrugged Off Safety Rules, Jury Told
- J&J Unit Presses Pa. Judge To Toss $57M Pelvic Mesh Verdict
- Ky. AG Hires Motley Rice, Others In Opioid Fight
- Mass. Digital Health Developments: What To Know Now
- Herbalife Scams Consumers With 'Event System,' Suit Says
- 11th Circ. Seeks Texas Justices' Input In J&J Mesh Suit
- Momenta, Amphastar Fight Jury Decision In $1B Patent Suit
- Dow's Appeal Of $455M Award To High Court Won't Be Easy
- Doctor Tearfully Recalls Outbreak In Meningitis Murder Trial
- 1st Pa. County Sues Opioid Makers Over Addiction Epidemic
- Investors Seek Fees While Altor-NantCell Deal Suit Goes On
- Italy's €183M Pharma Antitrust Case Gets Boost From EU AG
- Breckenridge Admits Sensipar Generic Violates Amgen Patent
- FDA Warns Of Liver Damage, Deaths With Intercept Drug
- Extending CalPERS V. ANZ Securities To Exchange Act Cases
- CEO's Oversight Doesn't Merit $1M Tax Penalty, Judge Says
- Feds Fight Shkreli Bid To Release $5M In Bail Funds
- Recent Cases Provide Hope For Reverse-Payment Defendants
- What The DOJ's Elite Health Fraud Squads Are Watching
- 3rd Circ. Lets GSK Win Stand In Wellbutrin Pay-For-Delay Row
- J&J Unit Must Face Whistleblower's Retaliation Case
- Germany-Based Schenck Valued At More Than €700M In Sale
- The Role Legal Finance Can Play In Firm Year-End Collections
- Patent For Cholesterol Drug Livalo Is Valid, Judge Rules
- Calif. Jury Clears Vestagen In Med-Scrub False Ad Trial
- New Trial Granted In DePuy Hip Replacement Litigation
- New Group Aims To Protect American IP In Trade Deals
- Gore Can't Slip Invalidity Verdict In Stent Patent Row
- Xarelto Bellwether Loser Says New Study Merits Retrial
- J&J Blocking Remicade Biosimilar Sales, Pfizer Says
- 4th Bellwether Over J&J Metal Hip Implants Kicks Off
- Miami Woman Gets 4 Years For Spa Silicone Injection Scheme
- Fla. Doctor Gets 8 Years For Role In $4.8M Medicare Fraud
- OvaScience Board Seeks Derivative Case Transfer To Mass.
- Meningitis Murder Trial Dogged By Accusations Jurors Misled
- Caution In Mixing Methadone, Benzos Can Reduce Risk: FDA
- Goodwin Procter DQ Bid Pauses Teva-Impax Indemnity Suit
- FDA Cherry-Picking Record In Sensipar Case, Amgen Says
- Alibaba-Backed Best Leads 5 IPOs Raising Nearly $1B
- $146M Deal In Aggrenox Pay-For-Delay MDL Gets Initial OK
- It's On Plaintiffs To Prove No Scientific Substantiation
- 'Per-Doc' Pricing Can Improve Document Review
- Medical Scrubs Cos. Start Trial Trading False Ad, IP Claims
- InSys Says Board Acted On Compliance Issues With Narcotic
- Maine Lab Accuses Chinese University Of Selling Its Mice
- Wellstat Wins $56M In Row With Chemo Antidote Sales Partner
- Warner Chilcott Seeks Out Of Asacol Antitrust Suit
- AstraZeneca, Amneal Settle Generic Diabetes Drug Fight
- Pa. AG Touts Efforts Regarding Trump, Equifax, Opioid Makers
- Pharmacy Solely Liable For Meningitis Outbreak, Clinic Says
- FDA Warning Wire: More Belladonna Teething Pills Draw Ire
- Bayer, Janssen Win Denial Of New Xarelto Trials
- Feds Seek 51-Plus Months For Ex-Hunton Atty's Tipping
- Catalent Makes $950M Bid To Buy Cook Pharmica
- State AGs Widen Probe Into Opioid Makers, Distributors
- Pharmacist Killed Patients By Shunning Safety, Jury Told
- Troutman Sanders Nabs Mintz Levin Litigators In Calif.
- Mass. Opioid Substitution Law A Nice Idea, But Falls Short
- Ex-K&L Gates Atty Escapes Sanctions Over Withheld Evidence
- FTC Contests Impax's Defense Of Opana ER Patent Settlement
- As Medical Food Industry Grows, So May FDA Scrutiny
- A Review Of Willfulness Findings In Hatch-Waxman Actions
- Securities Cases To Watch In Massachusetts
- 3 Takeaways From Delaware's TC Heartland Venue Guidance
- AbbVie Failed To Study Risks Of AndroGel, Jury Told
- Siemens Tells 1st Circ. Brook Cleanup Verdicts Should Stand
- Hospira Tells Jury Biosimilar Was Covered By Safe Harbor
- Cancer-Focused Biotechs Launch 2 IPOs Totaling $200M
- Teva Sells Off Remaining Women's Health Assets For $1.4B
- Novo Nordisk, Benefits Co. Get Price Hike Suit Moved To NJ
- Fla. Pharmacist, Staffer Convicted For $30M Tricare Fraud
- 3rd Circ. Ends Suit Over UPenn Nuclear Researcher's Cancer
- Medical Co. Employee Defends Retaliation Claim In FCA Case
- What To Watch For In 2nd Meningitis Murder Case
- Forest Labs Seeks Quick Win In Celexa, Lexapro MDL
- Failure To Show Personal Jurisdiction In 'Show Me' State
- Large And Small Cyberrisk Solutions For Health Care Cos.
- AbbVie AndroGel Patent Suits Baseless, Pa. Judge Finds
- Medix Hits Ex-Pharma Staffing Exec With Noncompete Suit
- NY Tribe's Attorney Defends Allergan Patent Deal
- 6 Firms To Steer IPOs Worth $1.6B As E-Commerce Leads Way
- Allergan IP Deal With Tribe Could Have Big Impact On PTAB
- DOJ Director Turned Sessions Aide Tapped For Civil Division
- CEO's Unreported Bank Account Was No Accident, IRS Says
- Ill. Firm Wants Cut Of Suit It Didn't Work On, Ex-Client Says
- 2nd Circ. Axes J&J Win In Pfizer Advertising Feud
- Allergan To Pay $15M To End Asacol Antitrust Claims
- In 9th Circ., Facts Can Doom Forward-Looking Statements
- Are Opioids The New Tobacco?
- A Guide To The Executive Branch Official Nomination Process
- Fed. Circ. Affirms PTAB Nix Of MiMedx Tissue Graft Patent
- No New Trial For GSK In Suit Over Reed Smith Atty's Suicide
- Allergan Deal May Set Stage For More Tribal Patent Pacts
- Thoratec Hid Heart Device Risks, Investor Tells 9th Circ.
- Puma Investor Seeks Fees For $20M In Director-Pay Savings
- 'Rule Of 2' Need Only Be Met At Start Of Deal, GAO Says
- FDA Clears Amgen-Allergan Biosimilar Of Genentech's Avastin
- Alcon Fights Bid For Docs In Contact Lens Antitrust MDL
- Pain Clinic Can't Depose FDA In Meningitis Cases, Feds Say
- 3rd Circ. Wellbutrin Ruling May Hinder Pay-For-Delay Suits
- FDA Backs 1st Mobile App For Substance Use Disorders
- OIG's Warranty Safe Harbor Opinion And Value-Based Care
- Ransomware And Medical Devices: A Growing Risk
- Abbott Must Pay $38M Depakote Verdict, Mo. High Court Says
- Full Fed. Circ. Urged To Review Inequitable Conduct Ruling
- CBS Sheds Doc's Defamation Suit Over Pill Crisis Coverage
- California Proton Reaches Deal For Facility Transition
- PharMerica Investor Sues Over $1.4B KKR, Walgreens Buyout
- High Court Asked To Review Mass Action Challenge
- Martin Shkreli In Custody After Clinton Comments
- Dynavax Escapes Shareholder Suit Over Hepatitis Vaccine
- Small Cos. Need Relief From Audit Rules, SEC Panel Told
- 5th Circ. Affirms Toss Of FCA Suit Against AndroGel Maker
- AbbVie's Humira Patents Are Noninventive, Boehringer Says
- Ex-Hunton Atty Won't Get Do-Over Of Insider Trading Trial
- Kimberly-Clark Indemnity Suit Halted As Halyard's Proceeds
- Del. Chief Judge Sets Post-TC Heartland Venue Guidelines
- FDA Warning Wire: Strychnine In Homeopathic Drugs
- Dow Asks Justices To Weigh In On Bayer $455M Award Row
- Indicted Insys Execs Face October 2018 Trial
- Judge Dismisses Ixchel's Antitrust Claims Against Biogen
- DOJ Backs Biosimilar Makers In Info-Sharing Fight
- Calif. High Court Should Hear Antitrust Query, AG Says
- Panamanian Drug Payment Row Heads To Arbitration
- Special Master To Oversee Discovery In J&J Talc MDL
- Health Plans Want RICO Suit Against Abbott Rebooted
- Home DNA Testing Co. 23andMe Raises $250M
- What The Intel Decision Means For European Commission
- GCs Pick 5 Fave Firms For Their Product Liability Work
- PTAB Grants Celgene Rehearing In Cancer Drug Challenge
- FDA Chief Backs Streamlined Studies To Curb Drug Costs
- Drugmakers Slam Ohio AG's Suit Over Opioid Crisis
- Impax Can't Stay Teva Suit During Goodwin Procter Appeal
- Diarrhea Drug Abuse Shouldn't End OTC Sales, FDA Hears
- 1st Circ. FCA Ruling May Spawn 'Parasitic' Suits, J&J Says
- Squire Patton Boggs Adds Obama IT Chief As Adviser
- Supreme Court Applied 'Settled Principles' In BMS Ruling
- Why More Global Giants Are Renouncing Their HQs
- Law360 Reveals The Global 20 Firms Of 2017
- Firms Stay The Course On London Growth Amid Brexit Haze
- Where The Global 20 Are Bolstering Their Ranks
- Global Firms Snap Up India Work With Liberalization In Limbo
- AmerisourceBergen Eyes $260M Deal In Criminal FDA Case
- 8th Circ. Again Revives FCA Suit Over Bayer Cholesterol Drug
- UK Drugmaker Can't Dodge States' Suboxone Case Just Yet
- Shkreli Looks To Kill Conspiracy Charge Post-Trial
- Amgen Set To Face Off With Hospira In Biosimilar IP Trial
- Galena To Pay $7.5M To Settle Opioid Kickback Suit
- Allergan Transfers Restasis Patents To IPR-Immune Tribe
- Innoviva Warns Of Bad Precedent Risk In Proxy Drop Battle
- Pa. Marijuana Grower Failed To Disclose Probe, Suit Says
- 3rd Circ. Keeps Grand Jury Seal In Bone Cement Test Suit
- Buchanan Ingersoll Scores Merchant & Gould Drug Patent Pro
- Doc Says Anti-SLAPP Law Can't Sink Defamation Suit
- J&J Unit Escapes Bulk Of Surgical Stapler Liability Suit
- Taxation With Representation: Wachtell, DLA, Simpson
- J&J Mesh Cases Belong In Philly, Out-Of-State Residents Say
- Ex-Covidien Employee Can't Escape Contract Breach Suit
- FDA Slams EpiPen Maker For Not Investigating Defects
- Supplement Co. Wins Partial Dismissal Of False Ad Suit
- Health Hires: AIG, Debevoise, Hinckley, K&L, PhRMA, Stinson
- Aligning A Product's Marketing, Regulatory And IP Plans
- How Collaboration Is Changing Inside Some Law Firms
- Profs Urge 3rd Circ. To Rethink GSK Win In Wellbutrin Case
- Kite Pharma Investors Balk At $11.9B Gilead Deal
- Feds Want Shkreli's Bail Revoked Over Clinton 'Threat'
- Swiss Pharma Co. Seeks OK On Cystic Fibrosis Drug Award
- Luxembourg Decision On $383M Award An Outlier, Court Told
- No Kickback Fines For Pharmacy Discounts, HHS OIG Says
- Travel Agency Leads 4 IPO Launches Totaling $375M
- Sanofi Beats Eye Doctor's TCPA Suit Over 13-Year-Old Fax
- $4.5M Deal In False Supplement Ad Suit Gets Final Nod
- FDA Invites Public To Weigh In On Regulatory Reform
- J&J Defends Privileged Docs In Contact Lens Antitrust MDL
- J&J Slammed With $57M Verdict In Philly Mesh Case
- 4 Cases That Will Guide The Future Of TTAB Proceedings
- Dealing With Difficult Lawyers
- Theranos Gets Class Limited To Indirect Share Purchasers
- McCaskill Slams Opioid Drugmaker Over Sales Efforts
- Daiichi Wants In On RoxyBond Rival's FDA Challenge
- Praxair Prevails In Mallinckrodt's Respiratory Drug Patent Suit
- FDA Releases Guidance On Connected Medical Devices
- NY Pharmacist Pleads Guilty To Illegal Distribution Scheme
- Impax To Pay $4.8M To End 'Fax-Blasting' Suit
- CORRECTION: AbbVie Can't Argue AndroGel Suit Too Late
- Ex-Roche Worker, Insurer Settle Suit Over Malpractice Ruling
- Punitive Damages In Mass Torts: Outrageous And Reckless
- Novo Nordisk Pays $60M To End Probe Into Drug Marketing
- Judge's Meddling Undoes Bio-Med Convictions, Justices Told
- Illumina Blasts Ariosa's $100M Counterclaim In Patent Suit
- FDA Warning Wire: Unapproved Surgeries On Kids Draw Fire
- SEC Inks $6.5M Deal In Marijuana Stock Fraud Row
- IRS Can Keep Docs Out Of CEO's $1M Tax Penalty Trial
- Philly Jurors Start Work As 6th Pelvic Mesh Trial Wraps
- CTI BioPharma Settles Investor Testing Info Row For $20M
- Saul Ewing, Arnstein & Lehr Merger Yields 15-Office Firm
- Simpson Thacher Guides Teleflex's $1.1B Bid For NeoTract
- Failed Biotech's Investors Warn Of 'Chilling' Wage Suit
- Merck Asks Supreme Court To Halt Fosamax Warning MDL
- Calif. High Court Tax Decision Could Be A Pyrrhic Victory
- 5th Circ. Wants Texas Hip Implant Bellwether Axed
- Fed. Circ. Affirms CardiAQ Win In $112M Trade Secret Row
- Taxation With Representation: Skadden, Sullivan, Hogan
- Fired Pharma Exec Not Victim Of Retaliation, 3rd Circ. Says
- Nightstar Marks Latest Foreign Biotech To File US IPO
- Dr. Reddy's Cleared Of Infringing Suboxone Patents
- Get 'Ultra-High Dose' Opioids Off Market, FDA Is Urged
- CIT Raps Commerce For Agilent Duty Ruling
- HHS Seeks Another Delay Of 340B Drug Price Ceilings
- 3rd Circ. Asked To Rethink Wellbutrin Pay-For-Delay Ruling
- Shkreli Trial And Other Magic Tricks: A Chat With Ben Brafman
- LabMD Says FTC Can't Delay 1st Amendment Case Appeal
- Can You Stop Photography During An FDA Inspection?